Relmada Therapeutics Share Price (NASDAQ: RLMD)
$1.12
▲
0.34
(43.59%)
Last updated on
Check the interactive Relmada Therapeutics Stock chart to analyse performance
Relmada Therapeutics stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$0.84Today's High:$1.16
24.67%
Downside
Day's Volatility :26.95%
Upside
3.03%
- 52 Weeks Low:$0.2452 Weeks High:$3.98
78.54%
Downside
52 Weeks Volatility :93.96%
Upside
71.86%
Relmada Therapeutics Stock Returns
Relmada Therapeutics Inc Key Stats
Check Relmada Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Relmada Therapeutics Stock including INR - Dollar returns
The Relmada Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Relmada Therapeutics investment value today
Current value as on today
₹45,284
Returns
Returns from Relmada Therapeutics Stock
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Relmada Therapeutics Stock
Global Institutional Holdings in Relmada Therapeutics Inc
Name
Holdings %
Acadian Asset Management LLC
3.70%
BlackRock Inc
1.71%
AdvisorShares Investments, LLC
1.19%
Vanguard Group Inc
1.10%
Geode Capital Management, LLC
0.91%
Deutsche Bank AG
0.68%
Analyst Recommendation on Relmada Therapeutics Stock
Buy
63%Buy
36%Hold
0%Sell
Based on 11 Wall street analysts offering stock ratings for Relmada Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Relmada Therapeutics Share Price Target
What analysts predicted
Downside of 10.71%
Target:
$1.00
Current:
$1.12
Relmada Therapeutics share price target is $1.00, a slight Downside of 10.71% compared to current price of $1.12 as per analysts' prediction.
Relmada Therapeutics Stock Insights
Price Movement
In the last 7 days, RLMD stock has moved up by 77.0%RLMD vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 130.3%RLMD vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 208.7%
Relmada Therapeutics Technicals Summary
Sell
Neutral
Buy
Relmada Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Relmada Therapeutics Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 88.01% | 335.29% | -59.49% | -96.3% | -96.93% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 1.77% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -1.15 | -1.75 | -0.96 | NA | 0.48 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $25.7M | -96.93% | NA | 0.0% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Relmada Therapeutics Inc
Key Management of Relmada Therapeutics Inc
Important FAQs about investing in RLMD Stock from India :
What is Relmada Therapeutics share price today?
Relmada Therapeutics share price today is $1.12 as on at the close of the market. Relmada Therapeutics share today touched a day high of $1.16 and a low of $0.84.
What is the 52 week high and 52 week low for Relmada Therapeutics share?
Relmada Therapeutics share touched a 52 week high of $3.98 and a 52 week low of $0.24. Relmada Therapeutics stock price today i.e. is closed at $1.12, lower by 71.86% versus the 52 week high.
How to invest in Relmada Therapeutics Stock (RLMD) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Relmada Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Relmada Therapeutics Shares that will get you 1.3393 shares as per Relmada Therapeutics share price of $1.12 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Relmada Therapeutics Stock (RLMD) from India?
Indian investors can start investing in Relmada Therapeutics (RLMD) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Relmada Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Relmada Therapeutics share’s latest price of $1.12 as on August 30, 2025 at 1:29 am IST, you will get 8.9286 shares of Relmada Therapeutics. Learn more about
fractional shares .
What are the returns that Relmada Therapeutics has given to Indian investors in the last 5 years?
Relmada Therapeutics stock has given -96.93% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
Grupo Aval Acciones Y Valores S.a.$3.33
-0.89%